首页> 外国专利> Medicament for inducing tolerance to antigens, e.g. those causing autoimmune disease, allergy or infections, containing the antigen together with steroid sulfatase inhibitor as adjuvant to improve tolerance induction

Medicament for inducing tolerance to antigens, e.g. those causing autoimmune disease, allergy or infections, containing the antigen together with steroid sulfatase inhibitor as adjuvant to improve tolerance induction

机译:用于诱导对抗原的耐受性的药物,例如那些引起自身免疫性疾病,变态反应或感染的人,含有抗原和类固醇硫酸酯酶抑制剂作为佐剂,以改善耐受性诱导

摘要

A medicament (A) contains as active component a combination of a steroid sulfatase (SS) inhibitor (I) and an antigen (II). An independent claim is included for a composition comprising (I) and (II). ACTIVITY : Immunosuppressive; antiallergic; antirheumatic; antiarthritic; neuroprotective; ophthalmological; antiinflammatory; antidiabetic; dermatological; antibacterial; virucidal; antifungal; antitubercular. In tolerance tests involving experimental autoimmune encephalitis in rats (an animal model of multiple sclerosis), administration of SS inhibitors (e.g. 1-8 mg of estrone-3-O-sulfamate (Ia) in oil, subcutaneously) before sensitization markedly reduced the amount of antigen (i.e. MBP or MOG) required to produce tolerance (no quantitative results given). MECHANISM OF ACTION : Steroid sulfatase inhibitor; vaccine.
机译:药物(A)包含类固醇硫酸酯酶(SS)抑制剂(I)和抗原(II)的组合作为活性成分。对于包含(I)和(II)的组合物包括独立权利要求。活动:免疫抑制;抗过敏抗风湿性抗关节炎神经保护眼科的消炎(药;抗糖尿病皮肤;抗菌;杀人的抗真菌药抗结核的。在涉及实验性自身免疫性脑炎的大鼠(多发性硬化症动物模型)的耐受性测试中,致敏前皮下注射SS抑制剂(例如皮下注射1-8 mg的雌酮-3-O-氨基磺酸酯(Ia),皮下注射)可明显减少该剂量产生耐受性的抗原(即MBP或MOG)的数量(未给出定量结果)。作用机理:类固醇硫酸酯酶抑制剂。疫苗。

著录项

  • 公开/公告号DE10005643A1

    专利类型

  • 公开/公告日2001-08-16

    原文格式PDF

  • 申请/专利权人 BIONETWORKS GMBH;

    申请/专利号DE20001005643

  • 发明设计人 WICKENS THOMAS;

    申请日2000-02-09

  • 分类号A61K39/39;

  • 国家 DE

  • 入库时间 2022-08-22 01:09:59

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号